143 related articles for article (PubMed ID: 17661994)
1. Is cerebral involvement an occasional feature of muscle-specific kinase antibody-positive syndrome?
Bhagavati S; Maccabee PJ; Chari G
Eur J Neurol; 2007 Aug; 14(8):e21-2. PubMed ID: 17661994
[No Abstract] [Full Text] [Related]
2. Anti-musk antibody after thymectomy in a previously seropositive myasthenic child.
Saulat B; Maertens P; Hamilton WJ; Bassam BA
Neurology; 2007 Aug; 69(8):803-4. PubMed ID: 17709714
[No Abstract] [Full Text] [Related]
3. Rituximab in the management of refractory myasthenia gravis.
Zebardast N; Patwa HS; Novella SP; Goldstein JM
Muscle Nerve; 2010 Mar; 41(3):375-8. PubMed ID: 19852027
[TBL] [Abstract][Full Text] [Related]
4. Vocal cord paralysis in myasthenia gravis with anti-MuSK antibodies.
Hara K; Mashima T; Matsuda A; Tanaka K; Tomita M; Shiraishi H; Motomura M; Nishizawa M
Neurology; 2007 Feb; 68(8):621-2. PubMed ID: 17310039
[No Abstract] [Full Text] [Related]
5. Autoimmune myasthenia gravis in childhood.
Andrews PI
Semin Neurol; 2004 Mar; 24(1):101-10. PubMed ID: 15229797
[TBL] [Abstract][Full Text] [Related]
6. Pre- and postsynaptic neuromuscular junction abnormalities in musk myasthenia.
Niks EH; Kuks JB; Wokke JH; Veldman H; Bakker E; Verschuuren JJ; Plomp JJ
Muscle Nerve; 2010 Aug; 42(2):283-8. PubMed ID: 20544919
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome.
Díaz-Manera J; Rojas-García R; Gallardo E; Juárez C; Martínez-Domeño A; Martínez-Ramírez S; Dalmau J; Blesa R; Illa I
Nat Clin Pract Neurol; 2007 Jul; 3(7):405-10. PubMed ID: 17611489
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic hematopoietic cell transplantation for refractory myasthenia gravis.
Strober J; Cowan MJ; Horn BN
Arch Neurol; 2009 May; 66(5):659-61. PubMed ID: 19433668
[TBL] [Abstract][Full Text] [Related]
9. Late onset generalized myasthenia gravis presenting with facial weakness and bulbar signs without extraocular muscle involvement.
Cucurachi L; Cattaneo L; Gemignani F; Pavesi G
Neurol Sci; 2009 Aug; 30(4):343-4. PubMed ID: 19484183
[TBL] [Abstract][Full Text] [Related]
10. Dropped head syndrome as prominent clinical feature in MuSK-positive Myasthenia Gravis with thymus hyperplasia.
Spengos K; Vassilopoulou S; Papadimas G; Tsivgoulis G; Karandreas N; Zambelis T; Manta P
Neuromuscul Disord; 2008 Feb; 18(2):175-7. PubMed ID: 18053719
[TBL] [Abstract][Full Text] [Related]
11. Nonresponsiveness to anticholinesterase agents in patients with MuSK-antibody-positive MG.
Hatanaka Y; Hemmi S; Morgan MB; Scheufele ML; Claussen GC; Wolfe GI; Oh SJ
Neurology; 2005 Nov; 65(9):1508-9. PubMed ID: 16275854
[No Abstract] [Full Text] [Related]
12. Longstanding right-hand weakness in a patient with myasthenia gravis.
de Carvalho M; Geraldes R
Muscle Nerve; 2006 Nov; 34(5):670-1. PubMed ID: 16878322
[No Abstract] [Full Text] [Related]
13. Unusual case of recurrent falls: myasthenia gravis in an elderly patient.
Alaama T; Basharat P; Nicolle MW
Can Fam Physician; 2012 Nov; 58(11):1231-2. PubMed ID: 23152461
[No Abstract] [Full Text] [Related]
14. Transient neonatal myasthenia gravis in a baby born to a mother with new-onset anti-MuSK-mediated myasthenia gravis.
O'carroll P; Bertorini TE; Jacob G; Mitchell CW; Graff J
J Clin Neuromuscul Dis; 2009 Dec; 11(2):69-71. PubMed ID: 19955986
[TBL] [Abstract][Full Text] [Related]
15. Myasthenia gravis crisis.
Bershad EM; Feen ES; Suarez JI
South Med J; 2008 Jan; 101(1):63-9. PubMed ID: 18176295
[TBL] [Abstract][Full Text] [Related]
16. Early-onset acquired myasthenia gravis secondary to anti-muscle-specific kinase autoantibodies.
Yilmaz S; Gokben S; Serdaroglu G; Akcay A
J Child Neurol; 2014 Jan; 29(1):108-10. PubMed ID: 23234677
[TBL] [Abstract][Full Text] [Related]
17. Long-term effect of intravenous immunoglobulin on anti-MuSK antibody-positive myasthenia gravis.
Shibata-Hamaguchi A; Samuraki M; Furui E; Iwasa K; Yoshikawa H; Hayashi S; Yamada M
Acta Neurol Scand; 2007 Dec; 116(6):406-8. PubMed ID: 17986100
[TBL] [Abstract][Full Text] [Related]
18. Different characteristic phenotypes according to antibody in myasthenia gravis.
Oh SJ; Morgan MB; Lu L; Hatanaka Y; Hemmi S; Young A; Claussen GC
J Clin Neuromuscul Dis; 2012 Dec; 14(2):57-65. PubMed ID: 23172384
[TBL] [Abstract][Full Text] [Related]
19. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody.
Punga AR; Flink R; Askmark H; Stålberg EV
Muscle Nerve; 2006 Jul; 34(1):111-5. PubMed ID: 16453324
[TBL] [Abstract][Full Text] [Related]
20. Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients.
Zhou L; McConville J; Chaudhry V; Adams RN; Skolasky RL; Vincent A; Drachman DB
Muscle Nerve; 2004 Jul; 30(1):55-60. PubMed ID: 15221879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
